Ajanta Pharma Ltd. - Research Center
532331 AJANTPHARM Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 3,971.12 | 3,411.27 | 3,140.64 | 2,718.59 | 2,196.42 |
| Expenses | |||||
| Material consumed | 1,128.17 | 1,071.74 | 887.01 | 767.42 | 698.49 |
| Manufacturing expenses | 66.44 | 65.53 | 54.09 | 43.42 | 38.56 |
| Personnel expenses | 834.16 | 720.41 | 585.87 | 498.11 | 437.82 |
| Selling expenses | 4.49 | 5.02 | 4.78 | 1.62 | 1.40 |
| Adminstrative expenses | 818.43 | 849.29 | 718.00 | 491.11 | 487.37 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 2,851.69 | 2,711.99 | 2,249.75 | 1,801.68 | 1,663.64 |
| Operating profit | 1,119.43 | 699.28 | 890.89 | 916.91 | 532.78 |
| Other recurring income | 116.48 | 132.75 | 139.73 | 103.57 | 184.20 |
| Adjusted PBDIT | 1,235.91 | 832.03 | 1,030.62 | 1,020.48 | 716.98 |
| Financial expenses | 6.80 | 5.23 | 9.12 | 6.90 | 9.10 |
| Depreciation | 132.16 | 126.95 | 120.96 | 111.49 | 91.29 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 1,096.95 | 699.85 | 900.54 | 902.09 | 616.59 |
| Tax charges | 289.71 | 141.13 | 180.68 | 226.45 | 171.54 |
| Adjusted PAT | 807.24 | 558.72 | 719.86 | 675.64 | 445.05 |
| Non recurring items | - | - | - | - | -3.92 |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | 807.24 | 558.72 | 719.86 | 675.64 | 441.13 |
| Earnigs before appropriation | 3,896.53 | 3,253.70 | 2,845.69 | 2,241.15 | 1,681.43 |
| Equity dividend | 642.17 | 89.69 | 82.21 | 51.26 | 110.96 |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | - | 31.64 | 2.48 |
| Retained earnings | 3,254.36 | 3,164.01 | 2,763.48 | 2,158.25 | 1,567.99 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis